The Global Pathogen Analysis System (GPAS) aims to improve global health by providing rapid, accessible and standardised genomic analysis for a range of pathogens, starting with SARS-CoV-2. Built by a long-established world-leading pathogen genomics team from Oxford University, supported by the cloud computing scale and security of Oracle Inc. GPAS is a global, turn-key solution that systematises how data from genomic sequencing is processed. 


Building on our successful SARS-CoV-2 toolset, GPAS will scale rapidly to analyse a range of pathogens, including M. tuberculosis, and deliver these solutions to laboratories, hospitals and public health organisations around the globe. 

Health Care

Health Data

Life Sciences

Medical Devices

Global Pathogen Analysis Service Ltd

Andrew McInerney

Corinna Bull

Vian van der Berg

Sarah Surrall

Kumeren Govender

Global Pathogen Analysis Service Ltd

Org chart

Similar companies